Clinical Trial Update: A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing valdecoxib to rofecoxib for acute pain due to ankle sprain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Rofecoxib (rofecoxib)
• Valdecoxib (valdecoxib)

Snippet

Sponsor: Pfizer | Conditions: Acute Pain | Phase 4 | Status: TERMINATED